R. Grempler < R. Grondin < R. Gross

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
003151 (2003)	A. Hadj Tahar [Canada] ; R. Grondin ; L. Grégoire ; F. Calon ; T. Di Paolo ; P J Bédard	New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
003323 (2003)	A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]	New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
003860 (2000)	M. Goulet [Canada] ; R. Grondin ; M. Morissette ; S. Maltais ; P. Falardeau ; P J Bédard ; T. Di Paolo	Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
003866 (2000)	R. Grondin [Canada] ; A. Hadj Tahar ; V D Doan ; P. Ladure ; P J Bédard	Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.
003875 (2000)	F. Calon [Canada] ; R. Grondin ; M. Morissette ; M. Goulet ; P J Blanchet ; T. Di Paolo ; P J Bédard	Molecular basis of levodopa-induced dyskinesias.
003A94 (2000)	M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys
003B15 (2000)	F. Calon [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; T. T. Di Paolo [Canada] ; P. J. Bedard [Canada]	Molecular basis of levodopa-induced dyskinesias
003B47 (2000)	F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	125I-CGP 64213 binding to GABAB receptors in the brain of monkeys : Effect of MPTP and dopaminomimetic treatments
003B98 (1999)	R. Grondin [Canada] ; V D Doan ; L. Grégoire ; P J Bédard	D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.
003C02 (1999)	R. Grondin [Canada] ; P J Bédard ; A. Hadj Tahar ; L. Grégoire ; A. Mori ; H. Kase	Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.
003E13 (1999)	V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]	Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
003E15 (1999)	R. Grondin [Canada] ; M. Goulet [Canada] ; M. Morissette [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958
003E18 (1999)	R. Grondin [Canada] ; V. D. Doan ; L. Gregoire ; P. J. Bedard	D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys
003E22 (1999)	F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]	Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys : effects on basal ganglia GABAA/ benzodiazepine receptor complex and GABA content
003E26 (1999)	R. Grondin [Canada] ; P. J. Bedard [Canada] ; A. Hadj Tahar [Canada] ; L. Gregoire [Canada] ; A. Mori [Japon] ; H. Kase [Japon]	Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
003E80 (1998)	M. Morissette ; M. Goulet ; R. Grondin ; P. Blanchet ; P J Bédard ; T. Di Paolo ; D. Lévesque	Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
004098 (1997)	R. Grondin [Canada] ; P J Bédard ; D R Britton ; K. Shiosaki	Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
004297 (1997)	R. Grondin [Canada] ; P. J. Bedard [Canada] ; D. R. Britton [États-Unis] ; K. Shiosaki [États-Unis]	Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929 : An acute study in parkinsonian levodopa-primed monkeys
004370 (1996)	M. Goulet [Canada] ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.
004373 (1996)	P J Blanchet [Canada] ; R. Grondin ; P J Bédard ; K. Shiosaki ; D R Britton	Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.
004380 (1996)	J P Doucet [Canada] ; Y. Nakabeppu ; P J Bedard ; B T Hope ; E J Nestler ; B J Jasmin ; J S Chen ; M J Iadarola ; M. St-Jean ; N. Wigle ; P. Blanchet ; R. Grondin ; G S Robertson	Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "R. Grondin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "R. Grondin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    R. Grondin
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022